- Home
- Results news
- National Peroxide
- Q1 FY27 results
National Peroxide Q1 FY27 results: net profit ₹6.61 crore vs ₹0.89 crore, revenue up 44.1%
National Peroxide Limited reported standalone Q1 FY27 revenue of ₹96.07 crore and a net profit of ₹6.61 crore. Revenue rose 44.1% from the year-ago quarter, while profit and EBITDA margin improved from Q1 FY26 but declined sequentially from Q4 FY26.
Key points
- Revenue was ₹96.07 crore in Q1 FY27, up 44.1% from ₹66.66 crore in Q1 FY26 and 12.1% from ₹85.68 crore in Q4 FY26.
- EBITDA was ₹12.24 crore, up 153.9% from ₹4.82 crore year on year but down 17.7% from ₹14.88 crore in the previous quarter.
- EBITDA margin was 12.7%, compared with 7.2% in Q1 FY26 and 17.4% in Q4 FY26.
- Net profit was ₹6.61 crore, up 642.7% from ₹0.89 crore year on year and down 16.6% from ₹7.93 crore in the previous quarter.
- Basic EPS was ₹11.5, compared with ₹1.55 in Q1 FY26 and ₹13.8 in Q4 FY26.
How did National Peroxide perform in Q1 FY27?
National Peroxide reported standalone revenue of ₹96.07 crore in Q1 FY27, compared with ₹66.66 crore in Q1 FY26 and ₹85.68 crore in Q4 FY26. The year-on-year increase was 44.1%, while the sequential increase was 12.1%. Total income was ₹98.19 crore, up 43.0% from ₹68.68 crore and 12.8% from ₹87.06 crore.
EBITDA was ₹12.24 crore, with a margin of 12.7%. It rose 153.9% from ₹4.82 crore in Q1 FY26, when the margin was 7.2%, but fell 17.7% from ₹14.88 crore in Q4 FY26, when the margin was 17.4%. Profit before tax was ₹8.83 crore, up 549.3% year on year but down 17.2% sequentially.
Net profit was ₹6.61 crore, compared with ₹0.89 crore in Q1 FY26 and ₹7.93 crore in Q4 FY26. Basic EPS was ₹11.5, against ₹1.55 a year earlier and ₹13.8 in the previous quarter. The available figures are standalone; the filing also enclosed unaudited limited-review reports for the quarter ended June 30, 2026.
| ₹ crore | Q1 FY27 | Q4 FY26 | Q1 FY26 | YoY | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 96.07 | 85.68 | 66.66 | +44.1% | +12.1% |
| Other income | 2.13 | 1.38 | 2.03 | +4.9% | +54.3% |
| Total expenses | 89.36 | 76.40 | 67.32 | +32.7% | +17.0% |
| EBITDA | 12.24 | 14.88 | 4.82 | +153.9% | −17.7% |
| EBITDA margin | 12.7% | 17.4% | 7.2% | +5.5 pp | −4.7 pp |
| Profit before tax | 8.83 | 10.66 | 1.36 | +549.3% | −17.2% |
| Tax | 2.22 | 2.73 | 0.47 | +372.3% | −18.7% |
| Net profit | 6.61 | 7.93 | 0.89 | +642.7% | −16.6% |
| EPS (₹) | 11.50 | 13.80 | 1.55 | +641.9% | −16.7% |
EBITDA here is revenue from operations less operating costs (total expenses excluding finance costs and depreciation): before other income and exceptional items. Growth is shown only when both figures are positive. Source: Company's results filing (XBRL).
What changed in National Peroxide's costs and profit?
Against Q1 FY26, cost of materials rose by ₹30.31 crore to ₹66.28 crore, employee cost rose by ₹0.50 crore to ₹7.58 crore, depreciation rose by ₹0.14 crore to ₹5.27 crore, and total expenses rose by ₹22.04 crore to ₹89.36 crore. Finance costs declined by ₹0.10 crore to ₹0.26 crore, while other expenses declined by ₹9.80 crore to ₹12.21 crore. Other income rose by ₹0.10 crore to ₹2.13 crore.
Tax expense rose by ₹1.75 crore to ₹2.22 crore. There was no exceptional item. The figures show higher revenue and other income, with the cost of materials also higher, while other expenses and finance costs declined; the filing excerpt does not state reasons for the quarter’s operating changes.
Sequentially, cost of materials rose by ₹16.13 crore to ₹66.28 crore, employee cost fell by ₹0.05 crore to ₹7.58 crore, finance costs fell by ₹0.06 crore to ₹0.26 crore, and depreciation fell by ₹0.01 crore to ₹5.27 crore. Other expenses fell by ₹1.45 crore to ₹12.21 crore, while other income rose by ₹0.75 crore to ₹2.13 crore. Tax expense fell by ₹0.51 crore to ₹2.22 crore, and there was no exceptional item.
| ₹ crore | Q1 FY27 | Q1 FY26 | Change | Change % |
|---|---|---|---|---|
| Cost of materials | 66.28 | 35.97 | +30.31 | +84.3% |
| Employee cost | 7.58 | 7.08 | +0.50 | +7.1% |
| Finance costs | 0.26 | 0.36 | −0.10 | −27.8% |
| Depreciation | 5.27 | 5.13 | +0.14 | +2.7% |
| Other expenses | 12.21 | 22.01 | −9.80 | −44.5% |
| Total expenses | 89.36 | 67.32 | +22.04 | +32.7% |
| Other income | 2.13 | 2.03 | +0.10 | +4.9% |
| Tax | 2.22 | 0.47 | +1.75 | +372.3% |
Source: Company's results filing (XBRL).
How has National Peroxide done over the last 8 quarters?
Revenue increased in each of the last three quarters, rising from ₹66.66 crore in Q1 FY26 to ₹68.29 crore in Q2 FY26, ₹69.09 crore in Q3 FY26 and ₹85.68 crore in Q4 FY26 before reaching ₹96.07 crore in Q1 FY27. The available series reached its lowest revenue at ₹62.16 crore in Q3 FY25 and its highest in the latest quarter.
Net profit recovered from ₹0.89 crore in Q1 FY26 to ₹1.83 crore in Q3 FY26 and ₹7.93 crore in Q4 FY26, before easing to ₹6.61 crore in Q1 FY27. EBITDA margin followed a similar shape, rising to 17.4% in Q4 FY26 before falling to 12.7% in the latest quarter from 10.1% in Q3 FY26.
What did the auditors point out?
The revised audit report for the quarter and year ended March 31, 2026 contained an unmodified opinion with an emphasis of matter. The auditors said the revised results gave a true and fair view of net profit, other comprehensive income and other financial information in accordance with the applicable requirements and accounting principles.
The emphasis of matter referred to the restatement of certain figures for the year ended March 31, 2026 because of an incorrect ERP configuration for processing natural-gas invoices, which had understated raw-material cost and overstated profit in the periods under revision. The auditors stated: “Our opinion is not modified in respect of the above matter.” The Q1 FY27 results were unaudited and accompanied by limited-review reports.
How did National Peroxide shares react?
The filing appeared during market hours. The stock was up 5.1% on the reaction day from its pre-results close of ₹582.5 and was unchanged after 5, 15 and 30 minutes from the price when the filing appeared. By the next day’s close it was up 10.3% from the pre-results close, and by the fifth session it was up 9.7%.
The Commodity Chemicals industry median fell 0.6% on the reaction day, 0.9% by the next day and 2.6% by five sessions. National Peroxide therefore exceeded the industry median by 5.6 percentage points on the reaction day, 11.2 percentage points by the next day and 12.3 percentage points by five sessions. Earlier reaction-day moves were 19.0% on 30 April 2026, 2.9% on 5 February 2026 and -0.9% on 3 November 2025.
| After the filing | Stock | Commodity Chemicals median |
|---|---|---|
| 5 minutes | +0.0% | |
| 15 minutes | +0.0% | |
| 30 minutes | +0.0% | |
| Reaction day | +5.1% | −0.6% |
| Next day | +10.3% | −0.9% |
| 5 days | +9.7% | −2.6% |
Minutes are measured from the price when the filing appeared; days from the previous close. Source: MarketPing price-reaction measurement.
| Results filed on | Stock on the reaction day |
|---|---|
| 30 April 2026 | +19.0% |
| 5 February 2026 | +2.9% |
| 3 November 2025 | −0.9% |
| 29 July 2025 | −2.3% |
| 6 May 2025 | −1.6% |
| 29 October 2024 | +2.6% |
| 31 July 2024 | +2.0% |
Source: MarketPing price-reaction measurement.
How did other Commodity Chemicals companies do?
Among 47 Commodity Chemicals companies compared for revenue growth, the median revenue growth was 17.0%. National Peroxide’s 44.1% revenue growth was higher than the median; 12 peers grew faster than the company and 34 grew slower than the company. Of 57 peers for which profit was compared, 39 reported higher profit.
| National Peroxide revenue growth (YoY) | +44.1% |
|---|---|
| Median of 47 other Commodity Chemicals companies | +17.0% |
| Companies with slower revenue growth than National Peroxide | 34 of 47 |
| Companies with faster revenue growth than National Peroxide | 12 of 47 |
| Companies whose net profit rose | 39 of 57 |
Source: Filed results (XBRL) of the industry's companies.
Quick answers
What was National Peroxide's revenue in Q1 FY27?
Revenue from operations was ₹96.07 crore, up 44.1% from ₹66.66 crore in Q1 FY26 (standalone).
Did National Peroxide make a profit in Q1 FY27?
Yes. Net profit was ₹6.61 crore, against a net profit of ₹0.89 crore in Q1 FY26.
What was National Peroxide's EPS in Q1 FY27?
Basic earnings per share were ₹11.50, against ₹1.55 in Q1 FY26.
How did National Peroxide shares react to the Q1 FY27 results?
On the reaction day the stock moved +5.1% from the previous close; the median Commodity Chemicals stock moved −0.6%.
When did National Peroxide announce its Q1 FY27 results?
On 12 August 2026, in a filing to the BSE.
Sources
- Board Meeting Intimation for Approval Of Unaudited Financial Results For Quarter Ended 30Th June, 2026. (BSE, 29 July 2026) · PDF
- Cancellation of Board Meeting (BSE, 2 August 2026) · PDF
- Board Meeting Intimation for Approval Of Financial Results (BSE, 9 August 2026) · PDF
- Board Meeting Outcome for Outcome Of Board Meeting Of The Company (BSE, 12 August 2026) · PDF
- Board Meeting Outcome for Outcome Of Board Meeting Of The Company (BSE, 12 August 2026) · PDF
- Statement Of Revised Audited Financial Results & Revised Audit Report For The Quarter And Financial Year Ended March 31, 2026: (BSE, 12 August 2026) · PDF
- Unaudited Financial Results For The Quarter Ended June 30,2026 (BSE, 12 August 2026) · PDF
- Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s (BSE, 12 August 2026) · PDF
- Fixation Of Annual General Meeting Of The Company (BSE, 12 August 2026) · PDF
- Details Of Book Closure Of Annual General Meeting (BSE, 12 August 2026) · PDF
- Corporate Action-Board approves Dividend (BSE, 12 August 2026) · PDF
How this was written: every figure in the tables and charts is calculated from the company’s filed results (XBRL) and MarketPing’s price measurements. The text is drafted with AI from those figures and the filings, and a checker removes any sentence carrying a number it cannot trace to them. How we write these.
This is information, not investment advice. MarketPing does not recommend buying or selling any security.